Best Price* ₹ 174.04 MRP ₹217.55 (Inclusive of all taxes) *This product cannot be returned for a refund or exchange. * Mkt: Novo Nordisk India Pvt Ltd * Country of Origin: India * Delivery charges if applicable will be applied at checkout
What is MIXTARD?
- MIXTARD contains the active substance in a mixture of 30% dissolved insulin and 70% isophane (NPH) insulin
- It is a dual-acting insulin with biphasic formulation containing fast-acting and long-acting insulin
What MIXTARD is used for?
- MIXTARD is used in the treatment of diabetes where your pancreas does not make enough insulin to control the level of glucose in your blood (blood sugar)
Talk to Doctor
Pregnancy & Breast Feeding
Children & Adolescents
Driving & Using Machines
Talk to your doctor before taking this medicine, if you:
- are allergic to the contents of MIXTARD
- get hypoglycaemia (low blood sugars)
- are traveling between different time zones, since this may mean that the patient must take insulin and meals at different times
- have heart, liver or kidney problems
- are alcoholic
- The amount of insulin you need usually falls during the first three months of pregnancy and increases for the remaining six months
- If you are breast-feeding, you may need to alter your insulin intake or diet
- If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine
- MIXTARD is not recommended for children and adolescents under 18 years
- Your ability to concentrate and react may be reduced if you have hypoglycaemia (low blood sugar)
- You should contact your doctor about the advisability of driving and using machines if you have frequent episodes of hypoglycaemia
Tell your doctor if you are taking, have recently taken or might take any other medicines such as,
- other medicines used to treat diabetes
- monoamine oxidase inhibitors (MAOI) such as selegiline
- beta-blocking agents may mask the symptoms of hypoglycaemia and delay recovery from hypoglycaemia
- octreotide/lanreotide may both decrease and increase insulin requirement.
- oral antidiabetic medication
- acetylsalicylic acid (aspirin)
- growth hormone
- beta-2 stimulants (for example ritodrine, salbutamol or terbutaline)
- thiazides or some antidepressants (monoamine oxidase inhibitors)
- danazol
- some angiotensin converting (ACE) inhibitors (for example captopril, enalapril) or angiotensin II receptor blockers
- Always use this medicine exactly as your doctor has told you
- This medicine is not to be used in insulin infusion pumps
- Dosage is individual and determined in accordance with the needs of the patient. The individual insulin requirement is usually between 0.3 and 1.0 IU/kg/day
- Close blood glucose monitoring is recommended
- An injection should be followed within 30 minutes by a meal or snack containing carbohydrates
Administration
- For subcutaneous (under the skin) use. Insulin suspensions are never to be administered into the vein
- MIXTARD is usually administered subcutaneously in the thigh or abdominal wall. Injection into a lifted skin fold
- The needle should be kept under the skin for at least 6 seconds to make sure the entire dose is injected
- Injection sites should be rotated within an anatomic region to avoid lipodystrophy
If you use more MIXTARD
- If you use more MIXTARD than you should, hypoglycemic episodes occur
- Mild hypoglycaemic episodes can be treated by oral administration of glucose or sugary products
- It is therefore recommended that diabetic patients constantly carry some sugar lumps, sweets, biscuits or sugary fruit juice
- In case of severe hypoglycemic episodes rush to the nearest hospital
If you forget to use MIXTARD
- If you forget to use MIXTARD, check your blood sugar. Do not inject a double dose to make up for a forgotten dose
If you stop using MIXTARD
- Do not change or stop MIXTARD unless your doctor tells you to do so
Like all medicines, this medicine can cause side effects, although not everybody gets them.
- rapid pulse
- hypoglycaemia (low blood sugar) or hyperglycemia (high blood sugar) that can cause headaches, nausea, vomiting, dehydration, unconsciousness, coma or even death
- local allergy marked by redness, swelling or itching around the area of the insulin injection
- lipodystrophy (thickening or pitting of the skin). if you notice your skin thickening or pitting at the injection site, change your injection site
- peripheral neuropathy
- oedema (e.g. swelling in arms, ankles; fluid retention), particularly at the start of insulin therapy or during a change in therapy to improve control of your blood glucose
- diabetic retinopathy (eye problems due to diabetes may worsen)
- injection site reactions (redness, swelling, itching, pain and haematoma at the injection site) may occur during treatment with insulin
- urticaria, rash
- low blood pressure
- rash over the whole body
- difficulty in breathing
- wheezing
- fast heart beat
- sweating
- generalized skin rash, itching
- fainting/loss of consciousness
- eye disorders
- Keep this medicine out of reach of children
- Before the first use store MIXTARD in a refrigerator (2-8°C). Do not freeze
- You can keep your ‘in use’ vial or penfill at room temperature below (15-25°C) for up to 28 days
- Keep protected from sunlight
- Do not use this medicine after the expiry date
- Do not use this medicine if you notice it is colored or it has solid particles in it. Check this each time you inject yourself
PRODUCT DETAILS
Net Qty
1
Item Weight
100IU
Ingredient
REGULAR INSULIN) 50%+INSULIN SOLUBLE(HUMAN INSULIN+ISOPHANE INSULIN(NPH) 50%(100IU)
Hsn Code
30043110
FREQUENTLY BOUGHT TOGETHER
DISCLAIMER
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.
Copyright© 2021. All Rights Reserved.